Clearmind Medicine develops novel psychedelic medicines to solve widespread, yet under-served, health problems. With a strong medical management team and IP-protection, we can better the lives of millions.

Clear Focus: With a clear focus on alcohol abuse and binge drinking, Clearmind's first drug candidate addresses very common (and costly) afflictions which to date, have limited solutions.

World-Class Management: Clearmind’s Chief Scientific Officer is a prolific inventor of international acclaim. Pair that with a proven leader in the pharmaceutical space and you have a powerful combination.

IP-Protected Innovation: Clearmind focuses exclusively on IP-protected treatments. With granted patents in the U.S and EP, allowed CN application and a nearly allowed IN application, Clearmind is set to establish its own territory in a competitive space.

Clearmind Medicine Inc. (CSE:CMND)(FWB:CMYO) is a featured sponsored company and has paid SmallCapPower.com a fee for coverage. To learn more, see our full disclosure HERE >>

FINANCIAL ANALYSIS

CONTACT

Clearmind Medicine Inc. (CSE:CMND) 101 – 1220 W 6 Ave Vancouver, BC V6H1A5 Company Website

RECEIVE COMPANY UPDATES




PRESS RELEASE